Star Scientific Inc. says it's working with the Food and Drug Administration to avoid having to pull two dietary supplement products from the market.
The company's new CEO, Dr. Michael Mullan, held a short conference call Wednesday to discuss recent developments with investors.
The Richmond Times-Dispatch reports (http://bit.ly/1arUkoG) that Mullan acknowledged that Star Scientific could be required to discontinue marketing Anatabloc and CigRx as dietary supplements.
Last month, the FDA sent a warning letter to the company saying that the products contain a new dietary ingredient that requires federal approval before it can be marketed. Star Scientific did not seek such approval.
The agency also said the company's website improperly promotes Anatabloc as a drug by suggesting it can be used to treat various diseases.
Information from: Richmond Times-Dispatch, http://www.timesdispatch.com